{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:31Z","timestamp":1792788091786,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.anl.2026.08.009","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:03:27Z","timestamp":1787789007000},"page":"676-682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age-stratified clinical interpretation of AWGS2025 sarcopenia criteria in head and neck cancer treated with definitive chemoradiotherapy: Comparison with AWGS2019"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8123-1835","authenticated-orcid":false,"given":"Ryosuke","family":"Kitoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh-ichiro","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Takumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2026.08.009_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.anl.2026.08.009_bib2","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/jpen.2415","article-title":"Prevalence of sarcopenia in patients with solid tumors: A meta-analysis based on 81,814 patients","volume":"46","author":"Surov","year":"2022","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.anl.2026.08.009_bib3","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.afos.2021.03.002","article-title":"Sarcopenia and mortality in cancer: A meta-analysis","volume":"7","author":"Au","year":"2021","journal-title":"Osteoporos Sarcopenia"},{"key":"10.1016\/j.anl.2026.08.009_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MOO.0000000000000792","article-title":"Sarcopenia and its impact in head and neck cancer treatment","volume":"30","author":"de Bree","year":"2022","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2026.08.009_bib5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jand.2020.03.021","article-title":"The association between computed tomography-defined sarcopenia and outcomes in adult patients undergoing radiotherapy of curative intent for head and neck cancer: A systematic review","volume":"120","author":"Findlay","year":"2020","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.anl.2026.08.009_bib6","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/hed.27688","article-title":"Sarcopenia predicts short-term treatment-related toxicity in patients undergoing curative-intent therapy for head and neck cancer: A systematic review and meta-analysis","volume":"46","author":"Mascarella","year":"2024","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2026.08.009_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.oraloncology.2017.05.012","article-title":"Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer","volume":"71","author":"Wendrich","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anl.2026.08.009_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282015","article-title":"Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy","volume":"18","author":"Becker","year":"2023","journal-title":"PLOS One"},{"key":"10.1016\/j.anl.2026.08.009_bib9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1200\/JCO.2017.74.9457","article-title":"Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: A Phase III randomized noninferiority trial","volume":"36","author":"Noronha","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2026.08.009_bib10","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.3390\/cancers16203460","article-title":"Head and neck cancer and sarcopenia: An integrative clinical and functional review","volume":"16","author":"Endo","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anl.2026.08.009_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 Consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.anl.2026.08.009_bib12","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/s43587-025-01004-y","article-title":"A focus shift from sarcopenia to muscle health in the Asian Working Group for Sarcopenia 2025 consensus update","volume":"5","author":"Chen","year":"2025","journal-title":"Nat Aging"},{"key":"10.1016\/j.anl.2026.08.009_bib13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s40520-025-03174-6","article-title":"Sarcopenia\u2014The need for an Asian perspective","volume":"37","author":"Woo","year":"2025","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.anl.2026.08.009_bib14","doi-asserted-by":"crossref","first-page":"afae052","DOI":"10.1093\/ageing\/afae052","article-title":"The conceptual definition of sarcopenia: Delphi consensus from the global leadership initiative in sarcopenia (GLIS)","volume":"53","author":"Kirk","year":"2024","journal-title":"Age Ageing"},{"key":"10.1016\/j.anl.2026.08.009_bib15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s10147-018-01392-9","article-title":"Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin","volume":"24","author":"Hamauchi","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.anl.2026.08.009_bib16","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.21.01293","article-title":"Weekly cisplatin plus radiation for postoperative head and neck cancer (JCOG1008): A multicenter, noninferiority, Phase II\/III randomized controlled trial","volume":"40","author":"Kiyota","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2026.08.009_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.radonc.2019.04.023","article-title":"The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation","volume":"137","author":"Ganju","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.anl.2026.08.009_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2022.03.009","article-title":"Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients","volume":"170","author":"Karavolia","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.anl.2026.08.009_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clnu.2020.05.020","article-title":"Is skeletal muscle loss associated with chemoradiotherapy toxicity in nasopharyngeal carcinoma patients? A prospective study","volume":"40","author":"Huang","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.anl.2026.08.009_bib20","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.3390\/cancers14092094","article-title":"Sarcopenia and treatment toxicity in older adults undergoing chemoradiation for head and neck cancer: Identifying factors to predict frailty","volume":"14","author":"Morse","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anl.2026.08.009_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/cancers13040753","article-title":"Prospective evaluation of sarcopenia in head and neck cancer patients treated with radiotherapy or radiochemotherapy","volume":"13","author":"Thureau","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anl.2026.08.009_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.887156","article-title":"Impact and treatment of sarcopenia in patients undergoing radiotherapy: A multidisciplinary, AMSTAR-2 compliant review of systematic reviews and metanalyses","volume":"12","author":"Medici","year":"2022","journal-title":"Front Oncol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814626001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814626001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:19:24Z","timestamp":1792786764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814626001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0385814626001276"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2026.08.009","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-stratified clinical interpretation of AWGS2025 sarcopenia criteria in head and neck cancer treated with definitive chemoradiotherapy: Comparison with AWGS2019","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2026.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}